Skip to main
IRTC
IRTC logo

iRhythm Technologies (IRTC) Stock Forecast & Price Target

iRhythm Technologies (IRTC) Analyst Ratings

Based on 13 analyst ratings
Buy
Strong Buy 46%
Buy 38%
Hold 15%
Sell 0%
Strong Sell 0%

Bulls say

iRhythm Technologies Inc. is experiencing a positive outlook attributed to an increase in revenue expectations and a rise in the mean comparable group multiples. The company's advancements in ambulatory cardiac monitoring services, particularly through its proprietary Zio System, demonstrate strong volume and pricing trends in its business. The optimistic updates in financial projections reflect the company's effective integration of innovative technology in diagnosing arrhythmias, signaling a robust growth potential in the digital healthcare market.

Bears say

iRhythm Technologies faces significant challenges due to a highly competitive market for ambulatory cardiac monitoring solutions, where competitors may develop more effective products that could diminish iRhythm's market share and commercial opportunities. Additionally, the company's reliance on favorable reimbursement policies from public and private payors introduces financial uncertainty, as changes in coverage or reimbursement rates could adversely impact the adoption and profitability of its Zio service. Compounding these issues, iRhythm has a history of net losses, indicating ongoing financial struggles that suggest concerns regarding its long-term viability in the current healthcare landscape.

iRhythm Technologies (IRTC) has been analyzed by 13 analysts, with a consensus rating of Buy. 46% of analysts recommend a Strong Buy, 38% recommend Buy, 15% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of iRhythm Technologies and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About iRhythm Technologies (IRTC) Forecast

Analysts have given iRhythm Technologies (IRTC) a Buy based on their latest research and market trends.

According to 13 analysts, iRhythm Technologies (IRTC) has a Buy consensus rating as of Oct 14, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $180.23, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $180.23, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

iRhythm Technologies (IRTC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.